在非酒精性脂肪肝疾病中的冠状血管变化
1Department of Gastroenterology, KTO Karatay Universiy Medical School Medicana Affiliated Hospital, Konya, Turkiye. enver.a.dr@gmail.com.
Endokrynologia Polska
|October 12, 2023
概括
非酒精性脂肪肝 (NAFLD) 与心血管问题有关. 这项研究发现,NAFLD患者的冠状腺血管指数 (CVI) 降低,这表明眼睛的微血管变化,并证实NAFLD是一种多系统性疾病.
科学领域:
- 眼科医生 眼科 眼科
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是由于心血管疾病导致死亡的首要原因.
- 冠状小血管可能表明系统性血管健康.
- 这项研究研究了NAFLD对胆管微血管结构的影响.
研究的目的:
- 为了评估NAFLD对胸腔微血管结构的影响.
- 为了比较NAFLD和没有NAFLD的患者的胸腔血管变化.
- 探索NAFLD作为影响眼睛微血管的多系统性疾病.
主要方法:
- 在96名患者 (52名NAFLD患者,44名对照患者) 的前性研究中.
- 使用增强深度光学连贯断层扫描 (EDI-OCT) 进行测量.
- 评估的亚管冠状腺厚度 (SFCT) 和冠状腺血管指数 (CVI).
主要成果:
- 在NAFLD患者中,BMI,腰围,葡萄糖,尿酸,ALT,GT,总胆固醇,费里丁,胰岛素和HOMA-IR都较高.
- 在NAFLD和对照组之间的SFCT没有显著差异 (p=0.077).
- 状血管指数 (CVI) 在NAFLD组明显较低 (p=0.045).
结论:
- 这是第一个报告NAFLD患者胸腔血管变化的研究.
- NAFLD与状腺血管指数的降低有关,这表明微血管功能受损.
- 这些发现支持NAFLD作为一种多系统性疾病,具有潜在的眼部微血管影响.
更多相关视频
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.2K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.1K
相关概念视频
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...